PRESS RELEASE

from Semperit AG Holding (isin : AT0000785555)

EQS-Adhoc: Semperit AG Holding: Executive Board proposes basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022

EQS-Ad-hoc: Semperit AG Holding / Key word(s): Dividend
Semperit AG Holding: Executive Board proposes basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022

01-March-2023 / 17:31 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc information

Semperit Executive Board proposes basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022

Vienna, Austria, 1 March 2023 – The Executive Board of Semperit AG Holding has decided to propose to the Annual General Meeting a basic dividend of EUR 1.50 per share as well as a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for the 2022 financial year. This results in a total dividend proposal of a maximum of EUR 5.00 per share for the 2022 financial year (previous year: EUR 1.50 per share). The basic dividend will be paid out on 3 May 2023.

The entitlement to the additional dividend depends on the sale of the medical business (Sempermed; production of examination gloves including sales organisation first) by 30 September 2023. The closing of the sale of the medical business is, in particular, still subject to the approval of the foreign direct investment control and competition authorities.

The exact amount of the additional dividend proposal depends on the economic outlook and on organic and inorganic growth projects becoming more substantiated. The Executive Board will announce a more concrete additional dividend proposal in due time before the Annual General Meeting of Semperit AG Holding on 25 April 2023.

This one-time deviation from the dividend policy of Semperit AG Holding should be seen in light of the successful separation from the medical business.


 

For questions, please contact:
 

Alexander Kleedorfer 

Director Group Brand Management (interim),
Corporate Spokesperson 

+43 676 8715 8464
alexander.kleedorfer@semperitgroup.com
 Judit Helenyi
 
Director Investor Relations
 
 
+43 676 8715 8310
judit.helenyi@semperitgroup.com
 

 

www.semperitgroup.com

www.linkedin.com/company/semperit-ag

 


01-March-2023 CET/CEST News transmitted by EQS Group AG. www.eqs.com


Language:English
Company:Semperit AG Holding
Am Belvedere 10
1100 Wien
Austria
Phone:+43 1 79 777-310
Fax:+43 1 79 777-602
E-mail:judit.helenyi@semperitgroup.com
Internet:www.semperitgroup.com
ISIN:AT0000785555
Listed:Vienna Stock Exchange (Official Market)
EQS News ID:1572419

 
End of AnnouncementEQS News Service

1572419  01-March-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1572419&application_name=news&site_id=symex
See all Semperit AG Holding news